Dr. Hakhamian will assist in bringing the company’s new suite of technologies to market and help integrate scientific advancements into dental applications, according to a March 28 news release from Primal Health.
“I am honored to join Primal Health, an organization that stands at the forefront of dental innovation with one of the most unique and ingenious approaches at addressing oral pathologies,” said Dr. Hakhamian.
Primal Health’s new products include pHossident and PROtektinTM, which alter oral microbes’ ability to metabolize sugar and stimulate them to produce clinically-relevant outcomes, the release said.
